Dave and Amber are excited about the upcoming ADA Conference in New Orleans, Dave, a long-time attendee of the ADA Conference shares his experience from the past events with Amber who is attending for the first time. Both are looking forward to knowing about the new drugs by Eli Lilly that would definitely help diabetic patients around the world, in today’s episode both of them share their expectations for the said event as they reunite with friends after 2 years of restrictions from the pandemic.
[00:01 - 06:03] Opening Segment
Attending ADA Global Meeting 2022 in New Orleans
Reuniting with Friends and Familiar Faces
[06:04 - 9:29] What to Expect from this year’s ADA
Poster Session (research that has been done)
Eli Lilly's new drug during the conference
[9:30 - 9:29] Different views and opinions.
Diabetes has reached a point where it is no longer a mystery yet there are many questions left unanswered.
The community is strong and companies should be excited about the potential of the conference.
Anticipation that the attendance at the conference will be high.
If you have any questions, don’t hesitate to reach out!
LEAVE, SUBSCRIBE, REVIEW + help someone who wants to learn more about the diabetes way is and everything happening within it.
“I always like connecting with people and because I've been writing about diabetes for the past eight or nine years and doing all this stuff, meeting someone in person, and some of the other conferences I've gone to the takeaways thereof just connecting.”
– Amber Clour
“it's almost like a homecoming a lot of people I haven't been able to see in person, you know, these people become friends and there is a certain amount of comradery to be around your own.”